MCAM and cervical carcinoma: The opposite effects of lnc-FANCI-2 and MCAM on cervical cancer survival (Figure 8I and Figure 8H and Figure 8—figure supplement 2) show that the cervical cancer patients with a higher level of lnc-FANCI-2 (Liu et al., 2021) but a lower level of MCAM in the cervical tissue (Figure 8H and I and Figure 8—figure supplement 2) exhibited a better survival prognosis.